← Back to Search

Adults with Advanced Lung Cancer for Lung Cancer

N/A
Waitlist Available
Led By Katherine Ramos, Ph.D.
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks, 1 month follow-up (up to 4 months)
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study to use Self-system therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks, 1 month follow-up (up to 4 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks, 1 month follow-up (up to 4 months) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Patients That Complete SST Treatment Sessions
Patient Satisfaction With Treatment
Secondary study objectives
Depression as Measured by the Beck Depression Inventory (BDI-II) at 1-month Follow-up
Depression as Measured by the Beck Depression Inventory (BDI-II) at 12 Weeks
Depression as Measured by the Beck Depression Inventory (BDI-II) at Baseline
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Adults with Advanced Lung CancerExperimental Treatment1 Intervention
Older adults with stage III or stage IV lung cancer will be enrolled in the Self-System Therapy intervention to treat illness-related distress, depression, and to enhance self-efficacy via delivery of behavioral coping skills across a period of 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC)
2020
N/A
~30

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,812 Previous Clinical Trials
8,161,441 Total Patients Enrolled
Duke UniversityLead Sponsor
2,454 Previous Clinical Trials
2,971,674 Total Patients Enrolled
Katherine Ramos, Ph.D.Principal InvestigatorDuke University
3 Previous Clinical Trials
98 Total Patients Enrolled
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top